A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated.
| dc.contributor.author | Pei, G | |
| dc.contributor.author | Samama, P | |
| dc.contributor.author | Lohse, M | |
| dc.contributor.author | Wang, M | |
| dc.contributor.author | Codina, J | |
| dc.contributor.author | Lefkowitz, RJ | |
| dc.coverage.spatial | United States | |
| dc.date.accessioned | 2013-09-10T16:00:35Z | |
| dc.date.issued | 1994-03-29 | |
| dc.description.abstract | The beta 2-adrenergic receptor (beta 2AR) can be constitutively activated by mutations in the third intracellular loop. Whereas the wild-type receptor exists predominantly in an inactive conformation (R) in the absence of agonist, the mutant receptor appears to spontaneously adopt an active conformation (R*). We now demonstrate that not only is the mutant beta 2AR constitutively active, it is also constitutively desensitized and down-regulated. To assess whether the mutant receptor can constitutively engage a known element of the cellular desensitization machinery, the receptor was purified and reconstituted into phospholipid vesicles. These preparations retained the essential properties of the constitutively active mutant receptor: agonist-independent activity [to stimulate guanine nucleotide-binding protein (Gs)-GTPase] and agonist-specific increase in binding affinity. Moreover, the purified mutant receptor, in the absence of agonist, was phosphorylated by recombinant beta AR-specific kinase (beta ARK) in a fashion comparable to the agonist-occupied wild-type receptor. Thus, the conformation of the mutated receptor is equivalent to the active conformation (R*), which stimulates Gs protein and is identical to the beta ARK substrate. | |
| dc.identifier | ||
| dc.identifier.issn | 0027-8424 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Proceedings of the National Academy of Sciences | |
| dc.relation.ispartof | Proc Natl Acad Sci U S A | |
| dc.subject | Adrenergic beta-Agonists | |
| dc.subject | Amino Acid Sequence | |
| dc.subject | Animals | |
| dc.subject | CHO Cells | |
| dc.subject | Cricetinae | |
| dc.subject | Dose-Response Relationship, Drug | |
| dc.subject | GTP Phosphohydrolases | |
| dc.subject | Gene Expression Regulation | |
| dc.subject | Isoproterenol | |
| dc.subject | Molecular Sequence Data | |
| dc.subject | Mutation | |
| dc.subject | Phosphorylation | |
| dc.subject | Radioligand Assay | |
| dc.subject | Receptors, Adrenergic, beta-2 | |
| dc.subject | Recombinant Proteins | |
| dc.subject | Signal Transduction | |
| dc.title | A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Lefkowitz, RJ|0000-0003-1472-7545 | |
| pubs.author-url | ||
| pubs.begin-page | 2699 | |
| pubs.end-page | 2702 | |
| pubs.issue | 7 | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Biochemistry | |
| pubs.organisational-group | Chemistry | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Duke Cancer Institute | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Cardiology | |
| pubs.organisational-group | Pathology | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Trinity College of Arts & Sciences | |
| pubs.publication-status | Published | |
| pubs.volume | 91 |
Files
Original bundle
- Name:
- Pei_A constitutively active mutant b2 adrenergic receptor is constitutively desensitized and phosphorylated.pdf
- Size:
- 1.02 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version